PAR 1.89% 26.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1736

  1. 471 Posts.
    lightbulb Created with Sketch. 209
    Coppo's report today (Mon 21/06/2021) on the approvals for Phase 2 clinical trial treating MPS-VI subjects in Brazil with PPS announced on Friday from the great man himself Richard Coppleson who is also a loyal LT SH too! wink.png

    https://hotcopper.com.au/data/attachments/3288/3288134-53e11b8d40a0ddd264966a500336d822.jpg
    GLTA LTSHs & PLS DYOR!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
-0.005(1.89%)
Mkt cap ! $90.94M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $52.29K 199.4K

Buyers (Bids)

No. Vol. Price($)
2 105423 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 30145 14
View Market Depth
Last trade - 14.07pm 28/05/2024 (20 minute delay) ?
Last
26.3¢
  Change
-0.005 ( 0.96 %)
Open High Low Volume
26.0¢ 26.5¢ 25.8¢ 183399
Last updated 14.44pm 28/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.